| ISIN | LU1540960942 |
|---|---|
| Valor Number | 35006892 |
| Bloomberg Global ID | |
| Fund Name | HBM UCITS (Lux) Funds-HBM Global Healthcare Fund A USD Cap |
| Fund Provider |
HBM Partners AG
Zug, Schweiz Phone: +41 43 888 71 71 E-Mail: investorrelations@hbmpartners.com Web: www.hbmpartners.com |
| Fund Provider | HBM Partners AG |
| Representative in Switzerland |
FundPartner Solutions (Suisse) SA Genève 75 |
| Distributor(s) | FundPartner Solutions (Suisse) S.A. |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | The investment objective of the Sub-Fund is to achieve long-term capital gains, by pursuing a long/short strategy in the "healthcare" market. The goal is to generate a value trend that exceeds the performance of the SOFR (the “Benchmark”). No guarantee can be given that the investment objective will be achieved. |
| Peculiarities |
| Current Price * | 300.03 USD | 30.10.2025 |
|---|---|---|
| Previous Price * | 297.10 USD | 29.10.2025 |
| 52 Week High * | 300.03 USD | 30.10.2025 |
| 52 Week Low * | 220.95 USD | 08.04.2025 |
| NAV * | 300.03 USD | 30.10.2025 |
| Issue Price * | 300.03 USD | 30.10.2025 |
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 19,271,974 | |
| Unit/Share Assets *** | 2,388,076 | |
| Trading Information SIX | ||
| YTD Performance | +20.08% |
31.12.2024 - 30.10.2025
31.12.2024 30.10.2025 |
|---|---|---|
| YTD Performance (in CHF) | +6.04% |
31.12.2024 - 30.10.2025
31.12.2024 30.10.2025 |
| 1 month | +7.54% |
30.09.2025 - 30.10.2025
30.09.2025 30.10.2025 |
| 3 months | +17.49% |
30.07.2025 - 30.10.2025
30.07.2025 30.10.2025 |
| 6 months | +23.08% |
30.04.2025 - 30.10.2025
30.04.2025 30.10.2025 |
| 1 year | +10.75% |
30.10.2024 - 30.10.2025
30.10.2024 30.10.2025 |
| 2 years | +44.22% |
30.10.2023 - 30.10.2025
30.10.2023 30.10.2025 |
| 3 years | +34.28% |
31.10.2022 - 30.10.2025
31.10.2022 30.10.2025 |
| 5 years | +38.96% |
30.10.2020 - 30.10.2025
30.10.2020 30.10.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Eli Lilly and Co | 7.54% | |
|---|---|---|
| UCB SA | 6.81% | |
| AbbVie Inc | 6.36% | |
| Merus NV | 4.65% | |
| Abivax SA | 4.17% | |
| Stryker Corp | 4.06% | |
| Natera Inc | 3.98% | |
| Lonza Group Ltd | 3.64% | |
| Sandoz Group AG Registered Shares | 3.25% | |
| The Cooper Companies Inc | 3.01% | |
| Last data update | 30.09.2025 | |
| TER | 0.0215% |
|---|---|
| TER date | 31.01.2018 |
| Performance Fee *** | 15.00% |
| PTR | |
| Max. Management Fee *** | 1.60% |
| Ongoing Charges *** | 3.03% |
|
SRRI ***
|
|
| SRRI date *** | 30.09.2025 |